Consultants in Medical Oncology and Hematology

What Consultants in Medical Oncology and Hematology does

Consultants in Medical Oncology and Hematology (CMOH), founded in 1988 by Dr. John Sprandio, is a physician-owned independent medical oncology and hematology practice headquartered in Broomall, Pennsylvania, with 101-250 employees across three locations serving the Greater Philadelphia suburbs of Delaware, Montgomery, and Chester Counties. The practice diagnoses and treats a broad range of cancers (breast, lung, colorectal, lymphoma, leukemia) and blood disorders through chemotherapy, targeted therapy, hormone therapy, immunotherapy, bone marrow transplant evaluation, and supportive care, delivered under its trademarked Oncology Patient Centered Medical Home® model that coordinates all aspects of patient care.

CMOH's core technology is its proprietary care delivery architecture — the Oncology Patient Centered Medical Home, developed and refined over 36 years — supplemented by affiliation with US Oncology Research and The US Oncology Network, which grants patients access to community-based clinical trials across 60+ research sites. Operational technology includes the Navigating Care patient portal for appointment scheduling and information access, and a dedicated clinical trials program with named research coordinators. The practice holds registered trademarks on both "Oncology Patient Centered Medical Home" and "OPMCH."

The business operates on a fee-for-service medical model: revenue is generated through billing patients and insurance providers (Medicare, Medicaid, and commercial payors) for consultations, treatments, and procedures, with patient responsibility limited to standard co-pays and deductibles. Customer acquisition is primarily through physician referrals from primary care and specialists across the tri-county region, supplemented by patient self-referrals, word-of-mouth, and the practice's educational website content. CMOH is fully independent, explicitly not owned by or affiliated with Crozer Health or Prospect Medical Holdings despite operating two of its three locations within Crozer facilities.

Name

Consultants in Medical Oncology and Hematology

Legal name

Consultants in Medical Oncology and Hematology, PC

Website

https://cmoh.org

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

51–100 employees

Short description

CMOH is an independent physician-owned medical oncology and hematology practice founded in 1988, serving cancer and blood disorder patients across three Greater Philadelphia locations under its trademarked Oncology Patient Centered Medical Home model.

Ownership category

akta.pro rank

Product category

Medical Oncology and Hematology Services

NAICS

Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAFABAI

Ambulatory Oncology Centers (Outpatient Chemo/Radiation)

Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

Keywords

• Medical oncology services
• Hematology treatments
• Cancer care
• Chemotherapy infusion
• Oncology clinical trials

Headquarters

HQ city

Broomall

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Oncology and Hematology Services: The practice generates revenue through providing medical oncology and hematology healthcare services billed to patients and insurance providers. Services include chemotherapy, targeted therapy, hormone therapy, immunotherapy, and clinical trial participation. The practice operates on a fee-for-service basis with standard insurance billing and co-pay structures.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Consultants in Medical Oncology and Hematology is a physician-owned outpatient practice that diagnoses and treats cancer and blood disorders through medical oncology and hematology services. It administers chemotherapy, targeted therapy, hormone therapy, and immunotherapy in community infusion suites and enrolls eligible patients in clinical trials through US Oncology Research. Care is organized around its proprietary Oncology Patient Centered Medical Home® (OPCMH) model.

Product overview

Consultants in Medical Oncology and Hematology (CMOH) is a leading medical oncology and hematology practice offering comprehensive cancer care services through multiple locations in the Greater Philadelphia area. The practice operates as a unified care delivery model centered around the Oncology Patient Centered Medical Home®, developed by Dr. John Sprandio, which coordinates every aspect of patient care. CMOH's core services include chemotherapy, targeted therapy, hormone therapy, immunotherapy, and clinical trials, supported by a clinical trials program affiliated with US Oncology Research and The US Oncology Network. The practice provides specialized treatment for specific cancer types including breast cancer, lung cancer, colorectal cancer, lymphoma, and leukemia, along with supportive care services, second opinion consultations, and a patient portal for online access to medical information.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology and Hematology Treatment Services Core outpatient oncology and hematology service for adult patients diagnosed with cancer or blood disorders in the Greater Philadelphia region, delivered under the proprietary Oncology Patient Centered Medical Home® (OPCMH) coordinated-care model across three suburban offices.
• Chemotherapy Systemic chemotherapy administration delivered in on-site infusion suites at CMOH's three community offices for adult cancer patients in Greater Philadelphia.
• Targeted Therapy Molecularly targeted drug therapy tailored to tumor-specific biomarkers, administered to eligible CMOH cancer patients as part of individualized treatment plans.
• Hormone Therapy Endocrine-based cancer treatment (e.g., for breast and prostate cancers) provided to CMOH patients with hormone-receptor-positive malignancies.
• Immunotherapy Immune-based cancer therapy (e.g., checkpoint inhibitors and related biologics) administered to eligible CMOH patients.
• Oncology Clinical Trials Program Clinical-trial enrollment and management for eligible cancer patients, delivered through CMOH's affiliation with US Oncology Research, providing community-based access to investigational therapies.
• Supportive / Palliative Care Services Symptom-management and supportive care delivered alongside cancer treatment to improve quality of life and treatment tolerance for CMOH patients.
• Second Opinion Consultations Independent oncology second-opinion consultations for patients seeking confirmation or alternative treatment options for a cancer or hematologic diagnosis.

Quantifiable outcome

• Over 36 years of continuous operation serving the Greater Philadelphia community
• +1 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• US Oncology ResearchcoreStrategic or Co-development PartnerCMOH is affiliated with US Oncology Research, one of the largest community-based cancer research programs in the United States with over 60 research sites. This partnership provides CMOH patients access to clinical trials locally, keeping them close to home where they have family support. US Oncology Research has enrolled over 80,000 patients in clinical trials and contributed to nearly 100 FDA-approved cancer therapies.
• The US Oncology NetworkcoreStrategic or Co-development PartnerCMOH is part of The US Oncology Network, which provides access to advanced treatments and clinical trial opportunities. This affiliation allows the practice to offer premier cancer care without requiring patients to travel to large university cancer centers. The network supports community-based oncology practices in delivering cutting-edge treatments.

Scale indicators3 records

Recent moves1 record

Expansion highlights4 records

Others

• Abramson Cancer Center (Penn Medicine):
• Sarah Cannon Research Institute: One of the largest community-based clinical trial networks in oncology, comparable as an enabling partner organization (alongside US Oncology Research) that CMOH leverages to deliver clinical trials locally.

Direct peers

• Texas Oncology: One of the largest community-based oncology practices in the US, operating across Texas with similar multi-site medical oncology and hematology services, US Oncology Network affiliation, and clinical trials access. Highly comparable as a community oncology model at much larger scale.
• Florida Cancer Specialists & Research Institute: Large community oncology practice offering chemotherapy, immunotherapy, targeted therapy, and clinical trials across Florida. Directly comparable as a high-volume, independent community oncology and hematology provider with research affiliations.
• The Oncology Institute of Hope and Innovation: Community-based medical oncology and hematology practice with multi-site footprint and value-based care orientation. Comparable to CMOH in service line (medical oncology, hematology, infusion) though operating at much larger, multi-state scale.
• Tennessee Oncology: Independent community oncology practice serving Tennessee and surrounding states with medical oncology, hematology, and clinical trials through affiliations including OneOncology and Sarah Cannon Research Institute. Strong direct comparability on community oncology model.
• Regional Cancer Care Associates: Multi-site community oncology practice across the Mid-Atlantic and Northeast offering medical oncology, hematology, and infusion services. Comparable regional community oncology peer with similar referral-driven GTM and insurance reimbursement model.

Emerging players

• OneOncology: Platform partnership organization partnering with independent community oncology practices like CMOH to provide scale benefits, technology, and research access. Comparable as a model that CMOH could affiliate with or against which it competes for partnership.

Broad incumbents

• US Oncology Network (McKesson): The large affiliated community oncology network that CMOH is already part of; provides research, technology, and purchasing scale. Comparable as the dominant incumbent network in community oncology that CMOH leverages and competes within.
• Cleveland Clinic Taussig Cancer Institute: Major academic cancer center providing medical oncology, hematology, and clinical trials. Comparable as a competitor for complex oncology referrals and clinical trial enrollment in the broader Mid-Atlantic oncology market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/opcmh

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Consultants in Medical Oncology and Hematology